Vitamin C in the treatment of schizophrenia.
This report concerns a 37-year-old chronic schizophrenic patient who derived substantial benefit from the addition of ascorbic acid (vitamin C) to his neuroleptic treatment. The case highlights the potential usefulness of vitamin C as an adjunctive agent in the treatment of chronic schizophrenia.
Sandyk
R
R
Department of Psychiatry, Albert Einstein College of Medicine, Bronx, NY 10461.
Kanofsky
J D
JD
D000328:Adult; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
D006220:Haloperidol; D001205:Ascorbic Acid